Molecular chaperone function for myocilin

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7548-7555

  Anderssohn, Ann Marie ^a,b   Cox, Kalani ^a,b   O'Malley, Kevin ^b   Dees, Scott ^b   Hosseini, Mojgan ^a,c   Boren, Lacey ^b   Wagner, Anthony ^b   Bradley, John M ^a   Kelley, Mary J ^a   Acott, Ted S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF PORTLAND   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CHAPERONE; CITRATE SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MYOCILIN; RESTRICTION ENDONUCLEASE; CYTOSKELETON PROTEIN; ENDODEOXYRIBONUCLEASE DRDI; ENZYME INHIBITOR; EYE PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP)(PHOSPHORYLATING); GLYCOPROTEIN; TRABECULAR MESHWORK-INDUCED GLUCOCORTICOID RESPONSE PROTEIN; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ANIMAL CELL; ARTICLE; CELL STRESS; CONTROLLED STUDY; HEAT SHOCK; LIGHT SCATTERING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; SWINE; TRABECULAR MESHWORK; WESTERN BLOTTING; ANIMAL; CELL CULTURE; HEAT; MECHANICAL STRESS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CITRATE (SI)-SYNTHASE; CYTOSKELETAL PROTEINS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; EYE PROTEINS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (NADP+)(PHOSPHORYLATING); GLYCOPROTEINS; HOT TEMPERATURE; MOLECULAR CHAPERONES; STRESS, MECHANICAL; STRESS, PHYSIOLOGICAL; SWINE; TRABECULAR MESHWORK;

EID: 84856367752     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7723     Document Type: Article

References (92)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Shields MB. Textbook of Glaucoma. 4th ed. Baltimore: Williams & Wilkins; 1998.
3. Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668-670.
4. Alward WL, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med. 1998;338:1022-1027.
5. Michels-Rautenstrauss KG, Mardin CY, Budde WM, et al. Juvenile open angle glaucoma: fine mapping of the TIGR gene to 1q24.3-q25.2 and mutation analysis. Hum Genet. 1998;102:103-106.
6. Wiggs JL, Allingham RR, Vollrath D, et al. Prevalence of mutations in TIGR/myocilin in patients with adult and juvenile primary openangle glaucoma. Am J Hum Genet. 1998;63:1549-1552.
7. Polansky JR, Fauss DJ, Chen P, et al. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica. 1997;211:126-139.
8. Nguyen T, Chen P, Huang W, Chen H, Johnson D, Polansky J. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem. 1998;273:6341-6350.
9. Kubota R, Noda S, Wang Y, et al. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics. 1997;41:360-369.
10. Tamm E. Myocilin and glaucoma: facts and ideas. Retinal Eye Res. 2002;21:395-428.
11. Anholt RR, Petro AE, Rivers AM. Identification of a group of novel membrane proteins unique to chemosensory cilia of olfactory receptor cells. Biochemistry. 1990;29:3366-3373.
12. Russell P, Tamm ER, Grehn FJ, Picht G, Johnson M. The presence and properties of myocilin in the aqueous humor. Invest Ophthalmol Vis Sci. 2001;42:983-986.
13. Lütjen-Drecoll E, May CA, Polansky JR, Johnson DH, Bloemendal H, Nguyen TD. Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork. Invest Ophthalmol Vis Sci. 1998;39:517-525.
14. Ueda J, Wentz-Hunter K, Yue BY. Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes. Invest Ophthalmol Vis Sci. 2002;43:1068-1076.
15. Karali A, Russell P, Stefani FH, Tamm ER. Localization of myocilin/ trabecular meshwork-inducible glucocorticoid response protein in the human eye. Invest Ophthalmol Vis Sci. 2000;41:729-740.
16. Swiderski RE, Ross JL, Fingert JH, et al. Localization of MYOC transcripts in human eye and optic nerve by in situ hybridization. Invest Ophthalmol Vis Sci. 2000;41:3420-3428.
17. Kulkarni NH, Karavanich CA, Atchley WR, Anholt RR. Characterization and differential expression of a human gene family of olfactomedin-related proteins. Genet Res. 2000;76:41-50.
18. Adam MF, Belmouden A, Binisti P, et al. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedinhomology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet. 1997;6:2091-2097.
19. Fingert JH, Ying L, Swiderski RE, et al. Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res. 1998;8:377-384.
20. Goldwich A, Baulmann DC, Ohlmann A, Flugel-Koch C, Schocklmann H, Tamm ER. Myocilin is expressed in the glomerulus of the kidney and induced in mesangioproliferative glomerulonephritis. Kidney Int. 2005;67:140-151.
21. Ohlmann A, Goldwich A, Flugel-Koch C, Fuchs AV, Schwager K, Tamm ER. Secreted glycoprotein myocilin is a component of the myelin sheath in peripheral nerves. Glia. 2003;43:128-140.
22. Ueda J, Wentz-Hunter KK, Cheng EL, Fukuchi T, Abe H, Yue BY. Ultrastructural localization of myocilin in human trabecular meshwork cells and tissues. J Histochem Cytochem. 2000;48:1321-1330.
23. Sakai H, Shen X, Koga T, et al. Mitochondrial association of myocilin, product of a glaucoma gene, in human trabecular meshwork cells. J Cell Physiol. 2007;213:775-784.
24. Wentz-Hunter K, Ueda J, Shimizu N, Yue BY. Myocilin is associated with mitochondria in human trabecular meshwork cells. J Cell Physiol. 2002;190:46-53.
25. Stamer WD, Perkumas KM, Hoffman EA, Roberts BC, Epstein DL, McKay BS. Coiled-coil targeting of myocilin to intracellular membranes. Exp Eye Res. 2006;83:1386-1395.
26. Hoffman EA, Perkumas KM, Highstrom LM, Stamer WD. Regulation of myocilin-associated exosome release from human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2009;50:1313-1318.
27. Goldwich A, Scholz M, Tamm ER. Myocilin promotes substrate adhesion, spreading and formation of focal contacts in podocytes and mesangial cells. Histochem Cell Biol. 2009;131:167-180.
28. Ueda J, Yue BY. Distribution of myocilin and extracellular matrix components in the corneoscleral meshwork of human eyes. Invest Ophthalmol Vis Sci. 2003;44:4772-4779.
29. Filla MS, Liu X, Nguyen TD, et al. In vitro localization of TIGR/ MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest Ophthalmol Vis Sci. 2002;43:151-161.
30. Wentz-Hunter K, Kubota R, Shen X, Yue BY. Extracellular myocilin affects activity of human trabecular meshwork cells. J Cell Physiol. 2004;200:45-52.
31. Wentz-Hunter K, Ueda J, Yue BY. Protein interactions with myocilin. Invest Ophthalmol Vis Sci. 2002;43:176-182.
32. Tan JC, Peters DM, Kaufman PL. Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol. 2006;17:168-174.
33. Park BC, Shen X, Fautsch MP, Tibudan M, Johnson DH, Yue BY. Optimized bacterial expression of myocilin proteins and functional comparison of bacterial and eukaryotic myocilins. Mol Vis. 2006;12:832-840.
34. Fautsch MP, Vrabel AM, Johnson DH. The identification of myocilin-associated proteins in the human trabecular meshwork. Exp Eye Res. 2006;82:1046-1052.
35. Torrado M, Trivedi R, Zinovieva R, Karavanova I, Tomarev SI. Optimedin: a novel olfactomedin-related protein that interacts with myocilin. Hum Mol Genet. 2002;11:1291-1301.
36. Gobeil S, Letartre L, Raymond V. Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion. Exp Eye Res. 2006;82: 1017-1029.
37. Kim BS, Savinova OV, Reedy MV, et al. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol Cell Biol. 2001;21:7707-7713.
38. Gould DB, Miceli-Libby L, Savinova OV, et al. Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol Cell Biol. 2004;24:9019-9025.
39. Zillig M, Wurm A, Grehn FJ, Russell P, Tamm ER. Overexpression and properties of wild-type and Tyr437His mutated myocilin in the eyes of transgenic mice. Invest Ophthalmol Vis Sci. 2005;46:223-234.
40. Gould DB, Reedy M, Wilson LA, Smith RS, Johnson RL, John SW. Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma. Mol Cell Biol. 2006;26:8427-8436.
41. Fautsch MP, Bahler CK, Vrabel AM, et al. Perfusion of his-tagged eukaryotic myocilin increases outflow resistance in human anterior segments in the presence of aqueous humor. Invest Ophthalmol Vis Sci. 2006;47:213-221.
42. Zhang K, Kaufman RJ. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology. 2006;66:S102-S109.
43. Gobeil S, Rodrigue MA, Moisan S, et al. Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants. Invest Ophthalmol Vis Sci. 2004;45:3560-3567.
44. Caballero M, Rowlette LL, Borras T. Altered secretion of a TIGR/ MYOC mutant lacking the olfactomedin domain. Biochim Biophys Acta. 2000;1502:447-460.
45. Yam GH, Gaplovska-Kysela K, Zuber C, Roth J. Aggregated myocilin induces Russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma. Am J Pathol. 2007;170:100-109.
46. Jacobson N, Andrews M, Shepard AR, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet. 2001;10:117-125.
47. Zhou Z, Vollrath D. A cellular assay distinguishes normal and mutant TIGR/myocilin protein. Hum Mol Genet. 1999;8:2221-2228.
48. Zimmerman CC, Lingappa VR, Richards JE, Rozsa FW, Lichter PR, Polansky JR. A trabecular meshwork glucocorticoid response (TIGR) gene mutation affects translocational processing. Mol Vis. 1999;5:19.
49. Shepard AR, Jacobson N, Millar JC, et al. Glaucoma-causing myocilin mutants require the peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum Mol Genet. 2007;16:609-617.
50. Rothman JE. Polypeptide chain binding proteins: catalysts of protein folding and related processes in cells. Cell. 1989;59:591-601.
51. Pelham HR. Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell. 1986;46:959-961.
52. Hartl FU. Molecular chaperones in cellular protein folding. Nature. 1996;381:571-579.
53. Horwitz J. α-Crystallin can function as a molecular chaperone. Proc Natl Acad Sci U S A. 1992;89:10449-10453.
54. Kelley M, David L, Iwasaki N, Wright J, Shearer T. α-Crystalline chaperone activity is reduced by calpain II in vitro and in selenite cataract. J Biol Chem. 1993;268:18844-18849.
55. Wang K, Spector A. The chaperone activity of bovine alpha crystallin: interaction with other lens crystallins in native and denatured states. J Biol Chem. 1994;269:13601-13608.
56. Tamm ER, Russell P, Johnson DH, Piatigorsky J. Human and monkey trabecular meshwork accumulate alpha B-crystallin in response to heat shock and oxidative stress. Invest Ophthalmol Vis Sci. 1996;37:2402-2413.
57. Fuchshofer R, Welge-Lussen U, Lutjen-Drecoll E, Birke M. Biochemical and morphological analysis of basement membrane component expression in corneoscleral and cribriform human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47:794-801.
58. Welge-Lussen U, May CA, Eichhorn M, Bloemendal H, Lutjen-Drecoll E. αB-Crystallin in the trabecular meshwork is inducible by transforming growth factor-beta. Invest Ophthalmol Vis Sci. 1999;40:2235-2241.
59. Vittal V, Rose A, Gregory KE, Kelley MJ, Acott TS. Changes in gene expression by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci. 2005;46:2857-2868.
60. Buchner J, Schmidt M, Fuchs M, et al. GroE facilitates refolding of citrate synthase by suppressing aggregation. Biochemistry. 1991;30:1586-1591.
61. Wiech H, Buchner J, Zimmermann R, Jakob U. Hsp90 chaperones protein folding in vitro. Nature. 1992;358:169-170.
62. Johnson D. Myocilin and glaucoma: a TIGR by the tail? Arch Ophthalmol. 2000;118:974-978.
63. Alexander JP, Acott TS. Involvement of the Erk-MAP kinase pathway in TNF-alpha regulation of trabecular metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci. 2003;44:164-169.
64. Bradley JMB, Kelley MJ, Zhu XH, Anderssohn AM, Alexander JP, Acott TS. Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2001;42:1505-1513.
65. Buchner J, Grallert H, Jakob U. Analysis of chaperone function using citrate synthase as nonnative substrate protein. Methods Enzymol. 1998;290:323-338.
66. Cori GT, Slein MW, Cori CF. Crystalline d-glyceraldehyde-3-phosphate dehydrogenase from rabbit muscle. J Biol Chem. 1948;173: 605-618.
67. Cai H, Wang CC, Tsou CL. Chaperone-like activity of protein disulfide isomerase in the refolding of a protein with no disulfide bonds. J Biol Chem. 1994;269:24550-24552.
68. Tamm ER, Russell P, Epstein DL, Johnson DH, Piatigorsky J. Modulation of myocilin: TIGR expression in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1999;40:2577-2582.
69. Clark AF, Steely HT, Dickerson JE Jr, et al. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci. 2001;42: 1769-1780.
70. Vollrath D, Liu Y. Temperature sensitive secretion of mutant myocilins. Exp Eye Res. 2006;82:1030-1036.
71. Imaizumi K, Tohyama M. The regulation of unfolded protein response by OASIS, a transmembrane bZIP transcription factor, in astrocytes (in Japanese). Nippon Yakurigaku Zasshi. 2004;124: 383-390.
72. Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008;86:543-561.
73. Alvarado J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology. 1984;91:564-579.
74. Alvarado J, Murphy C, Polansky J, Juster R. Age-related changes in trabecular meshwork cellularity. Invest Ophthalmol Vis Sci. 1981;21:714-727.
75. Grierson I, Howes RC. Age-related depletion of the cell population in the human trabecular meshwork. Eye. 1987;1(pt 2):204-210.
76. Tschumper RC, Johnson DH. Trabecular meshwork cellularity: differences between fellow eyes. Invest Ophthalmol Vis Sci. 1990;31:1327-1331.
77. Liton PB, Challa P, Stinnett S, Luna C, Epstein DL, Gonzalez P. Cellular senescence in the glaucomatous outflow pathway. Exp Gerontol. 2005;40:745-748.
78. Ellis R. Chaperone function: the orthodox view. In: Henderson B, Pockley A, eds. Molecular Chaperones and Cell Signaling. New York: Cambridge University Press; 2006:3-21.
79. Horwitz J, Huang Q, Ding L, Bova M. Lens alpha-crystallin: chaperone-like properties. Methods Enzymol. 1998;290:365-383.
80. Sun Y, MacRae TH. Small heat shock proteins: molecular structure and chaperone function. Cell Mol Life Sci. 2005;62:2460-2476.
81. Tamm ER, Russell P. The role of myocilin/TIGR in glaucoma: results of the Glaucoma Research Foundation Catalyst Meeting in Berkeley, California, March 2000. J Glaucoma. 2001;10:329-339.
82. Bose S, Weikl T, Bugl H, Buchner J. Chaperone function of Hsp90-associated proteins. Science. 1996;274:1715-1717.
83. Das KP, Surewicz WK. On the substrate specificity of alpha-crystallin as a molecular chaperone. Biochem J. 1995;311(pt 2):367-370.
84. Ezzat M-K, Howell KG, Bahler CK, et al. Characterizatin of monoclonal antibodies against the glaucoma-associated protein myocilin. Exp Eye Res. 2008;87:376-384.
85. Das S, Mandal M, Chakraborti T, Mandal A, Chakraborti S. Structure and evolutionary aspects of matrix metalloproteinases: a brief overview. Mol Cell Biochem. 2003;253:31-40.
86. Das KP, Choo-Smith LP, Petrash JM, Surewicz WK. Insight into the secondary structure of non-native proteins bound to a molecular chaperone alpha-crystallin: an isotope-edited infrared spectroscopic study. J Biol Chem. 1999;274:33209-33212.
87. Das KP, Surewicz WK. Temperature-induced exposure of hydrophobic surfaces and its effect on the chaperone activity of alphacrystallin. FEBS Lett. 1995;369:321-325.
88. Horwich A, Weber-Ban E, Finley D. Chaperone rings in protein folding and degradation. Proc Natl Acad Sci U S A. 1999;96:11033-11040.
89. Fautsch MP, Johnson DH. Characterization of myocilin-myocilin interactions. Invest Ophthalmol Vis Sci. 2001;42:2324-2331.
90. Wentz-Hunter K, Shen X, Okazaki K, Tanihara H, Yue BY. Overexpression of myocilin in cultured human trabecular meshwork cells. Exp Cell Res. 2004;297:39-48.
91. Gruber HE, Ingram JA, Hanley EN Jr. Cellular immunohistochemical localization of the matricellular protein myocilin in the intervertebral disc. Biotechnol Histochem. 2006;81:119-124.
92. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002;14:608-616.